Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.

Witzens-Harig M, Reiz M, Heiss C, Benner A, Hensel M, Neben K, Dreger P, Kraemer A, Ho AD

Open source

DOI
10.1007/s00277-008-0560-2
Published
2009 Jan
Container
Annals of hematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00277-008-0560-2,
  title = {Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.},
  author = {Witzens-Harig M and Reiz M and Heiss C and Benner A and Hensel M and Neben K and Dreger P and Kraemer A and Ho AD},
  year = {2009},
  journal = {Annals of hematology},
  doi = {10.1007/s00277-008-0560-2},
  url = {https://doi.org/10.1007/s00277-008-0560-2}
}

RIS

TY  - JOUR
TI  - Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.
AU  - Witzens-Harig M
AU  - Reiz M
AU  - Heiss C
AU  - Benner A
AU  - Hensel M
AU  - Neben K
AU  - Dreger P
AU  - Kraemer A
AU  - Ho AD
PY  - 2009
JO  - Annals of hematology
DO  - 10.1007/s00277-008-0560-2
UR  - https://doi.org/10.1007/s00277-008-0560-2
ER  - 

APA

M, W., M, R., C, H., A, B., M, H., K, N., P, D., A, K., & AD, H. (2009). Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.. Annals of hematology. https://doi.org/10.1007/s00277-008-0560-2

Source records